Related Experiment Video
Updated: Aug 22, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
The direct antiglobulin test in a hospital setting
1Centre de Transfusió i Banc de Teixits, Tarragona. C/. Dr. Mallafré Guasch, 4, 43007 Tarragona, Spain.
Insights
The Direct Antiglobulin Test (DAT) is rarely positive in suspected hemolytic anemia cases. A comprehensive laboratory evaluation for hemolytic anemia should precede DAT testing for better diagnostic accuracy.
Area of Science:
- Clinical Pathology
- Hematology
- Immunology
Background:
- The Direct Antiglobulin Test (DAT) is a crucial diagnostic tool for suspected hemolytic anemia.
- Understanding the utility and appropriate utilization of DAT in clinical practice is essential.
Purpose of the Study:
- To assess the current application and diagnostic yield of the DAT in a hospital setting.
- To determine the correlation between DAT results and comprehensive laboratory evaluations for hemolytic anemia.
Main Methods:
- Retrospective chart review of 463 patients who underwent DAT testing between April 1999 and October 2001.
- Collected data included DAT results and findings from prior laboratory evaluations for hemolytic anemia.
- Analysis of DAT positivity rates based on the number of clinical signs of hemolysis.
Main Results:
- The DAT was negative in 93.7% (434/463) and positive in 6.3% (29/463) of cases.
- A complete laboratory evaluation for hemolytic anemia was performed in 38.7% (179/463) of patients.
- A higher incidence of positive DAT was observed in patients with more than two signs of hemolysis (11.8%) compared to those with two or fewer signs (3.4%).
Conclusions:
- The DAT demonstrates a low positivity rate in the evaluated patient population.
- A comprehensive laboratory workup for suspected hemolytic anemia should be prioritized before ordering a DAT.
- This approach may improve diagnostic efficiency and resource utilization in investigating anemia.
Abstract:
To evaluate the current use of the DAT in our hospital,we reviewed the charts of all patients who had a DAT performed in our laboratory. The collected data included DAT results and a previously completed laboratory evaluation of suspected hemolytic anemia. Four hundred sixty-three DATs were performed in our laboratory from April 1999 to October 2001. The DAT was negative in 434 (93.7%) cases and positive in 29 (6.3%) cases. A complete laboratory evaluation of suspected hemolytic anemia was seen in 179 (38.7%) cases. The incidence of a positive DAT was higher in the group of patients with > 2 signs of hemolysis (4/34 cases; 11.8%) than in the group of patients with = 2 signs of hemolysis (5/145 cases; 3.4%) (RR = 0.029;95% CI:0.08-1.03; p = 0.06). When a patient with anemia is being investigated, a complete laboratory evaluation for suspected hemolytic anemia should be done before performing a DAT.

